Drug makers, PBMs and drugstore chains involved in the sale and distribution of opioids may have reason to fear “a tobacco-style master settlement agreement,” Fitch Ratings says.
Billionaire investor Carl Icahn now says he will support Cigna’s proposed purchase of Express Scripts, citing recommendations of two influential proxy advisors who came out in favor of the merger.
CVS Health said its retained share of rebates negotiated with drug makers this year comes to 2%, which translates to $300 million or 3% of the company’s annual earnings per share.
Investor Carl Icahn went public Tuesday with his opposition to Cigna’s proposed purchase of Express Scripts, saying the health insurer is overpaying amid a challenging regulatory environment and the entrance of Amazon into the pharmacy business.